Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Schizophr Res ; 209: 72-79, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31126803

RESUMO

Patients with schizophrenia show impairment in processing faces, including facial affect and face detection, but the underlying mechanisms are unknown. We used functional magnetic resonance imaging (fMRI) to characterize resting state functional connectivity between an independent component analysis (ICA)-defined early visual cortical network (corresponding to regions in V1, V2, V3) and a priori defined face-processing regions (fusiform face area [FFA], occipital face area [OFA], superior temporal sulcus [STS] and amygdala) using dual regression in 20 schizophrenia patients and 26 healthy controls. We also investigated the association between resting functional connectivity and neural responses (fMRI) elicited by a face detection paradigm in a partially overlapping sample (Maher et al., 2016) that used stimuli equated for lower-level perceptual abilities. Group differences in functional connectivity were found in right FFA only; controls showed significantly stronger functional connectivity to an early visual cortical network. Functional connectivity in right FFA was associated with (a) neural responses during face detection in controls only, and (b) perceptual detection thresholds for faces in patients only. The finding of impaired functional connectivity for right FFA (but not other queried domain-specific regions) converges with findings investigating face detection in an overlapping sample in which dysfunction was found exclusively for right FFA in schizophrenia during face detection.


Assuntos
Reconhecimento Facial/fisiologia , Esquizofrenia/diagnóstico por imagem , Lobo Temporal/diagnóstico por imagem , Córtex Visual/diagnóstico por imagem , Adulto , Tonsila do Cerebelo/diagnóstico por imagem , Tonsila do Cerebelo/fisiopatologia , Estudos de Casos e Controles , Feminino , Neuroimagem Funcional , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Vias Neurais/diagnóstico por imagem , Vias Neurais/fisiopatologia , Lobo Occipital/diagnóstico por imagem , Lobo Occipital/fisiopatologia , Esquizofrenia/fisiopatologia , Lobo Temporal/fisiopatologia , Córtex Visual/fisiopatologia , Adulto Jovem
2.
J Prev Alzheimers Dis ; 6(2): 112-120, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30756118

RESUMO

The study of individuals with autosomal dominant Alzheimer's disease affords one of the best opportunities to characterize the biological and cognitive changes of Alzheimer's disease that occur over the course of the preclinical and symptomatic stages. Unifying the knowledge gained from the past three decades of research in the world's largest single-mutation autosomal dominant Alzheimer's disease kindred - a family in Antioquia, Colombia with the E280A mutation in the Presenilin1 gene - will provide new directions for Alzheimer's research and a framework for generalizing the findings from this cohort to the more common sporadic form of Alzheimer's disease. As this specific mutation is virtually 100% penetrant for the development of the disease by midlife, we use a previously defined median age of onset for mild cognitive impairment for this cohort to examine the trajectory of the biological and cognitive markers of the disease as a function of the carriers' estimated years to clinical onset. Studies from this cohort suggest that structural and functional brain abnormalities - such as cortical thinning and hyperactivation in memory networks - as well as differences in biofluid and in vivo measurements of Alzheimer's-related pathological proteins distinguish Presenilin1 E280A mutation carriers from non-carriers as early as childhood, or approximately three decades before the median age of onset of clinical symptoms. We conclude our review with discussion on future directions for Alzheimer's disease research, with specific emphasis on ways to design studies that compare the generalizability of research in autosomal dominant Alzheimer's disease to the larger sporadic Alzheimer's disease population.


Assuntos
Doença de Alzheimer/fisiopatologia , Peptídeos beta-Amiloides/metabolismo , Encéfalo/diagnóstico por imagem , Fragmentos de Peptídeos/metabolismo , Presenilina-1/genética , Adolescente , Adulto , Doença de Alzheimer/diagnóstico por imagem , Doença de Alzheimer/genética , Doença de Alzheimer/metabolismo , Peptídeos beta-Amiloides/sangue , Peptídeos beta-Amiloides/líquido cefalorraquidiano , Compostos de Anilina , Doenças Assintomáticas , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Biomarcadores/metabolismo , Encéfalo/metabolismo , Encéfalo/fisiopatologia , Criança , Colômbia , Imagem de Tensor de Difusão , Progressão da Doença , Eletroencefalografia , Etilenoglicóis , Feminino , Neuroimagem Funcional , Humanos , Imageamento por Ressonância Magnética , Masculino , Testes de Estado Mental e Demência , Pessoa de Meia-Idade , Fragmentos de Peptídeos/sangue , Fragmentos de Peptídeos/líquido cefalorraquidiano , Tomografia por Emissão de Pósitrons , Compostos Radiofarmacêuticos , Tomografia Computadorizada de Emissão de Fóton Único , Adulto Jovem
3.
Neuropsychologia ; 50(5): 733-9, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22261399

RESUMO

An important issue for understanding visual perception in autism concerns whether individuals with this neurodevelopmental disorder possess an advantage in processing local visual information, and if so, what is the nature of this advantage. Perception of movement speed is a visual process that relies on computation of local spatiotemporal signals but requires the comparison of information from more than a single spatial location or temporal point. This study examined speed discrimination in adolescents (ages 13-18 years old) with autism spectrum disorders (ASD). Compared to healthy controls (n=17), individuals with ASD (n=19) showed similarly precise speed discrimination when two comparison motion stimuli (random dot patterns) were presented closely in time (0.5s). With a longer temporal interval (3s) between the motion stimuli, individuals with ASD outperformed healthy controls on speed discrimination. On a second task--global motion perception--in which individuals were asked to detect coherent motion, individuals with ASD exhibited slightly degraded performance levels. The observed temporally selective enhancement in speed discrimination indicates that a local processing advantage in autism develops over a longer temporal range and is not limited to the spatial domain. These results suggest a dynamic perceptual mechanism for understanding, and therapeutically addressing, atypical visual processing in this neurodevelopmental disorder.


Assuntos
Transtorno Autístico/fisiopatologia , Discriminação Psicológica/fisiologia , Percepção de Movimento/fisiologia , Adolescente , Análise de Variância , Feminino , Humanos , Testes de Inteligência , Masculino , Estimulação Luminosa , Escalas de Graduação Psiquiátrica
4.
J Neurosci Nurs ; 24(6): 354-8, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1289435

RESUMO

The declaration of death by neurological criteria has become more commonly accepted and used within the medical community, especially within the past 10 years. There remains, however, a great deal of misunderstanding and lack of awareness among health care professionals as to the criteria used to determine brain death and the importance of adhering to brain death determination protocols. Youngner et al, in their 1989 survey, found more than one-third of surveyed physicians involved in the decision-making process for brain death were still unable to correctly identify and apply the whole brain criteria needed to determine brain death. To some degree, this unfamiliarity can perhaps be explained by the infrequency with which brain death occurs. Physicians and nurses are usually not involved in brain death pronouncements more than a few times each year. Because of this, hospitals need to develop and maintain brain death protocols which are in keeping with the most current scientific literature and accepted medical practice.


Assuntos
Morte Encefálica/diagnóstico , Protocolos Clínicos/normas , Apneia/diagnóstico , Viés , Velocidade do Fluxo Sanguíneo , Circulação Cerebrovascular , Eletroencefalografia/métodos , Eletroencefalografia/normas , Potenciais Evocados Auditivos do Tronco Encefálico , Humanos , Exame Neurológico/métodos , Exame Neurológico/normas , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...